<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對照品 > 對照品 > 工作對照品 >
    1-(4-Aminophenyl)cyclopentanecarbonitrile-d8
    產(chǎn)品基本信息
    產(chǎn)品編號:A615552
    產(chǎn)品名稱:1-(4-Aminophenyl)cyclopentanecarbonitrile-d8
    產(chǎn)品CAS:
    規(guī)格含量:100mg
    產(chǎn)品價格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號: A615552
    名稱: 1-(4-Aminophenyl)cyclopentanecarbonitrile-d8
    備用CAS: 115279-73-7
    分子式: C??H?D?N?
    分子量: 194.3
    類別: Building Blocks; Isotopic Labeled Analogues; Miscellaneous;
    應(yīng)用: 1-(4-Aminophenyl)cyclopentanecarbonitrile-d8 is an intermediate used in the synthesis of Apatinib-d8 Hydrochloride (A726152), which is a labelled Apatinib (A726150). Apatinib is an orally available, small molecule multitargeted tyrosine kinase inhibitor. Apatinib selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2). Apatinib functions by inhibiting VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. Recent studies have shown that Apatinib enhances the efficacy of conventional chemotherapeutical drugs in side population (SP) cells and ABCB1-overexpressing leukemia cells.
    參考:


    2011-2018 信陽萊耀生物科技有限公司 @ 信陽埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      欧美精品久久久 | 黄色伊人网| 一级片视频播放 | 永久免费无码A片在线观看大豆网 | 我看操逼的 |